Sex Hormones and Aging

Part of paid clinical trials in Ann Arbor, Michigan.

Sponsor
University of Michigan
Study ID
NCT07848438
Status
Recruiting

Conditions

Eligibility Criteria

Sex
FEMALE
Age
50 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • HRT: High-Resistance Strength Training — OTHER
    Each participant will attend 2 sessions per week for 8 weeks. A training session will start with a 10-minute full body dynamic warm-up (e.g., bodyweight movements and mobility exercises). The participant will then perform bilateral lower body high-resistance strength training exercises (leg extension and leg press) for 4 sets of 8-10 repetitions.
  • Control: High-Resistance Strength Training — OTHER
    Each participant will attend 2 sessions per week for 8 weeks. A training session will start with a 10-minute full body dynamic warm-up (e.g., bodyweight movements and mobility exercises). The participant will then perform bilateral lower body high-resistance strength training exercises (leg extension and leg press) for 4 sets of 8-10 repetitions.

Study Details

This study investigates the influence of sex hormones and exercise on age-related neuromuscular decline in females. Specifically, the research aims to evaluate how hormonal variations impact both age-associated neuromuscular decline and the subsequent adaptations to exercise and resistance training. Age-related declines in neuromuscular function are especially pronounced in females, potentially due to the sharp drop in estradiol after menopause. This project will compare postmenopausal females who have not taken hormonal therapy (HT) to age-matched females taking HT.

Key Dates

First listed
Sep 30, 2026
Start date
Aug 20, 2026
Status verified
Sep 2026
Primary completion
Aug 31, 2031
Completion
Aug 31, 2031

Study Design

Enrollment
120 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Postmenopausal Hormone Therapy
    Postmenopausal females who are currently taking hormone replacement therapy
  • Experimental: Postmenopausal Female Controls
    Postmenopausal females who have no history of taking hormone replacement therapy

Primary Outcome Measure

Strength - Maximal Voluntary Contraction (MVC) [ Time Frame: One session before and then after 8 weeks of training ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MichiganAnn ArborMichigan48109
Sandra Hunter, PhD
(734) 647-6019
Sarah Lessila, MS

Find similar trials in Ann Arbor, MI

By condition

Related Studies